ID   SK-MEL-28
AC   CVCL_0526
SY   SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36
DR   BTO; BTO_0002131
DR   CLO; CLO_0009043
DR   EFO; EFO_0003081
DR   MCCL; MCC:0000426
DR   CLDB; cl4321
DR   CLDB; cl4954
DR   AddexBio; C0020001/66
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-72
DR   BCRJ; 0289
DR   BioSample; SAMN03470899
DR   BioSample; SAMN03472092
DR   BioSample; SAMN03472754
DR   BioSample; SAMN10987689
DR   cancercelllines; CVCL_0526
DR   CancerTools; 161917
DR   Cell_Model_Passport; SIDM00081
DR   CGH-DB; 9317-4
DR   ChEMBL-Cells; CHEMBL3308494
DR   ChEMBL-Targets; CHEMBL614919
DR   CLS; 300337
DR   Cosmic; 686472
DR   Cosmic; 686476
DR   Cosmic; 687442
DR   Cosmic; 706106
DR   Cosmic; 721824
DR   Cosmic; 851050
DR   Cosmic; 874384
DR   Cosmic; 874446
DR   Cosmic; 875887
DR   Cosmic; 886831
DR   Cosmic; 888846
DR   Cosmic; 897491
DR   Cosmic; 898252
DR   Cosmic; 905230
DR   Cosmic; 905954
DR   Cosmic; 928748
DR   Cosmic; 932712
DR   Cosmic; 933135
DR   Cosmic; 974072
DR   Cosmic; 974262
DR   Cosmic; 1006554
DR   Cosmic; 1007156
DR   Cosmic; 1022271
DR   Cosmic; 1045407
DR   Cosmic; 1047687
DR   Cosmic; 1054859
DR   Cosmic; 1067227
DR   Cosmic; 1092633
DR   Cosmic; 1102386
DR   Cosmic; 1109809
DR   Cosmic; 1132589
DR   Cosmic; 1155280
DR   Cosmic; 1155570
DR   Cosmic; 1175872
DR   Cosmic; 1183772
DR   Cosmic; 1187579
DR   Cosmic; 1221590
DR   Cosmic; 1238109
DR   Cosmic; 1295337
DR   Cosmic; 1303055
DR   Cosmic; 1305368
DR   Cosmic; 1312350
DR   Cosmic; 1425350
DR   Cosmic; 1458966
DR   Cosmic; 1459645
DR   Cosmic; 1477319
DR   Cosmic; 1477408
DR   Cosmic; 1507598
DR   Cosmic; 1598350
DR   Cosmic; 1665022
DR   Cosmic; 1669144
DR   Cosmic; 1995635
DR   Cosmic; 1998476
DR   Cosmic; 2159448
DR   Cosmic; 2479251
DR   Cosmic; 2560253
DR   Cosmic; 2651877
DR   Cosmic-CLP; 905954
DR   DepMap; ACH-000615
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905954
DR   GEO; GSM2115
DR   GEO; GSM50205
DR   GEO; GSM50267
DR   GEO; GSM156050
DR   GEO; GSM171012
DR   GEO; GSM188226
DR   GEO; GSM188256
DR   GEO; GSM188315
DR   GEO; GSM206543
DR   GEO; GSM228378
DR   GEO; GSM274690
DR   GEO; GSM276739
DR   GEO; GSM743468
DR   GEO; GSM750825
DR   GEO; GSM784506
DR   GEO; GSM799357
DR   GEO; GSM799420
DR   GEO; GSM844690
DR   GEO; GSM847116
DR   GEO; GSM887584
DR   GEO; GSM888667
DR   GEO; GSM952581
DR   GEO; GSM1138790
DR   GEO; GSM1153427
DR   GEO; GSM1153428
DR   GEO; GSM1181282
DR   GEO; GSM1181283
DR   GEO; GSM1588919
DR   GEO; GSM1670439
DR   GEO; GSM1671969
DR   GEO; GSM1671970
DR   GEO; GSM1671974
DR   GEO; GSM1671983
DR   GEO; GSM1671986
DR   GEO; GSM1671991
DR   GEO; GSM1671996
DR   GEO; GSM1672002
DR   GEO; GSM1672006
DR   GEO; GSM1672032
DR   GEO; GSM1672043
DR   GEO; GSM1672047
DR   GEO; GSM1672049
DR   GEO; GSM1672050
DR   GEO; GSM1672054
DR   GEO; GSM1672056
DR   GEO; GSM1672060
DR   GEO; GSM1672061
DR   GEO; GSM2124651
DR   GEO; GSM3039512
DR   IARC_TP53; 26113
DR   ICLC; HTL99010
DR   LiGeA; CCLE_529
DR   LINCS_HMS; 51101
DR   LINCS_LDP; LCL-2092
DR   NCI-DTP; SK-MEL-28
DR   PharmacoDB; SKMEL28_1396_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD007000
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0526
DR   PubChem_Cell_line; CVCL_0526
DR   RCB; RCB1930
DR   SKY/M-FISH/CGH; 2745
DR   TKG; TKG 0333
DR   Wikidata; Q54954013
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   Patent=US4591572;
RX   PubMed=313568;
RX   PubMed=327080;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1716514;
RX   PubMed=2041050;
RX   PubMed=2068080;
RX   PubMed=2983346;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6197381;
RX   PubMed=6203018;
RX   PubMed=6349783;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=9598804;
RX   PubMed=10700174;
RX   PubMed=10766161;
RX   PubMed=11016658;
RX   PubMed=11121133;
RX   PubMed=12068308;
RX   PubMed=12479222;
RX   PubMed=14692828;
RX   PubMed=14871852;
RX   PubMed=15009714;
RX   PubMed=15299072;
RX   PubMed=15467732;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17260012;
RX   PubMed=17308088;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=18277095;
RX   PubMed=18790768;
RX   PubMed=19147755;
RX   PubMed=19372543;
RX   PubMed=19799798;
RX   PubMed=20041153;
RX   PubMed=20164919;
RX   PubMed=20406486;
RX   PubMed=21424129;
RX   PubMed=21725359;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23285177;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24576830;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25950383;
RX   PubMed=25960936;
RX   PubMed=26405815;
RX   PubMed=26589293;
RX   PubMed=26673621;
RX   PubMed=27087056;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29492214;
RX   PubMed=30674989;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=47
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/skmel28-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-28
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-524.
CC   Population: Caucasian.
CC   Characteristics: Lightly pigmented.
CC   Doubling time: 27 hours (PubMed=7718330); 36 hours (PubMed=8631022); 72 hours (PubMed=12479222); 26.9 hours (PubMed=20406486); 35.1 hours (NCI-DTP=SK-MEL-28).
CC   HLA typing: A*11:01:01; B*40:01; C*03:04:01; DPB1*03:01:01; DQB1*03:02; DRB1*04:04 (PubMed=15748285).
CC   HLA typing: A*11:01,11:01; B*40:01,40:01; C*03:03,03:03; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*04:04,04:04 (PubMed=25960936).
CC   HLA typing: A*11:01,11:01; B*40:01,40:01; C*03:04,03:04; DQA1*03:02,05:02; DQB1*03:02,03:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=17088437; PubMed=17260012; PubMed=17363583; PubMed=19799798; PubMed=24576830; PubMed=26405815; PubMed=29492214; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=9598804; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (PubMed=10766161; PubMed=17260012; PubMed=17363583; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (PubMed=17088437; PubMed=17260012; PubMed=18277095; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.75%; Native American=0.56%; East Asian, North=3%; East Asian, South=1.38%; South Asian=8.29%; European, North=20.11%; European, South=64.91% (PubMed=30894373).
CC   Discontinued: RCB; RCB1930; true.
CC   Discontinued: TKG; TKG 0333; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB=RCB1930; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (PubMed=19372543; PubMed=25877200)
ST   CSF1PO: 10,12 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   D10S1248: 16
ST   D12S391: 15,19
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D19S433: 14
ST   D1S1656: 12
ST   D21S11: 28,29
ST   D22S1045: 11,15
ST   D2S1338: 18
ST   D2S441: 10,11
ST   D3S1358: 16,18
ST   D5S818: 11,13 (AddexBio=C0020001/66; ATCC=HTB-72; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   D5S818: 13 (CLS=300337; PubMed=19372543; PubMed=25877200)
ST   D7S820: 9.3,10 (AddexBio=C0020001/66; ATCC=HTB-72)
ST   D7S820: 10 (CLS=300337; Cosmic-CLP=905954; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 9,10
ST   Penta E: 8,12
ST   TH01: 7
ST   TPOX: 8,12 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   TPOX: 12 (PubMed=19372543; PubMed=25877200)
ST   vWA: 16,19 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=25877200; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   vWA: 19 (PubMed=19372543)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
CH   CVCL_6937 ! OCM-3
CH   CVCL_6938 ! OCM-8
CH   CVCL_J267 ! SK-MEL-28-Luc
CH   CVCL_AP99 ! SK-MEL-28-VR
CH   CVCL_IM75 ! SK-MEL-28DDR1-PLXAZD
CH   CVCL_IM76 ! SK-MEL-28R1-PLX
CH   CVCL_D4WQ ! SKMEL28-SLC13A3-KO-c3
CH   CVCL_D4WR ! SKMEL28-SLC13A3-KO-c4
//
RX   PubMed=6203018; DOI=10.1111/j.1348-0421.1984.tb00673.x;
RA   Maezawa, Nobuyoshi
RA   Yano, Akihiko
RT   "Two distinct cytotoxic T lymphocyte subpopulations in patients with
RT   Vogt-Koyanagi-Harada disease that recognize human melanoma cells.";
RL   Microbiol. Immunol. 28:219-231(1984).
//
RX   PubMed=15009714; DOI=10.1046/j.0022-202X.2004.22243.x; PMCID=PMC2586668;
RA   Tsao, Hensin
RA   Goel, Vikas
RA   Wu, Heng
RA   Yang, Guang
RA   Haluska, Frank G.
RT   "Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1
RT   inactivation in melanoma.";
RL   J. Invest. Dermatol. 122:337-341(2004).
//
RX   PubMed=19147755; DOI=10.1158/1078-0432.CCR-08-1916;
RA   Augustine, Christina K.
RA   Yoo, Jin Soo
RA   Potti, Anil
RA   Yoshimoto, Yasunori
RA   Zipfel, Patricia A.
RA   Friedman, Henry Seth
RA   Nevins, Joseph R.
RA   Ali-Osman, Francis
RA   Tyler, Douglas Scott
RT   "Genomic and molecular profiling predicts response to temozolomide in
RT   melanoma.";
RL   Clin. Cancer Res. 15:502-510(2009).
//
RX   PubMed=10700174; DOI=10.1038/73432;
RA   Ross, Douglas T.
RA   Scherf, Uwe
RA   Eisen, Michael Bruce
RA   Perou, Charles M.
RA   Rees, Christian
RA   Spellman, Paul T.
RA   Iyer, Vishwanath R.
RA   Jeffrey, Stefanie S.
RA   van de Rijn, Matt
RA   Waltham, Mark C.
RA   Pergamenschikov, Alexander
RA   Lee, Jeffrey C.F.
RA   Lashkari, Deval
RA   Shalon, Dari
RA   Myers, Timothy Gene
RA   Weinstein, John N.
RA   Botstein, David
RA   Brown, Patrick O'Reilly
RT   "Systematic variation in gene expression patterns in human cancer cell
RT   lines.";
RL   Nat. Genet. 24:227-235(2000).
//
RX   PubMed=25960936; DOI=10.4161/21624011.2014.954893; PMCID=PMC4355981;
RA   Boegel, Sebastian
RA   Lower, Martin
RA   Bukur, Thomas
RA   Sahin, Ugur
RA   Castle, John C.
RT   "A catalog of HLA type, HLA expression, and neo-epitope candidates in
RT   human cancer cell lines.";
RL   OncoImmunology 3:e954893.1-e954893.12(2014).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li, Jun
RA   Zhao, Wei
RA   Akbani, Rehan
RA   Liu, Wen-Bin
RA   Ju, Zhen-Lin
RA   Ling, Shi-Yun
RA   Vellano, Christopher P.
RA   Roebuck, Paul
RA   Yu, Qing-Hua
RA   Eterovic, Agda Karina
RA   Byers, Lauren Averett
RA   Davies, Michael A.
RA   Deng, Wan-Leng
RA   Gopal, Y.N. Vashisht
RA   Chen, Guo
RA   von Euw, Erika Maria
RA   Slamon, Dennis Joseph
RA   Conklin, Dylan
RA   Heymach, John Victor
RA   Gazdar, Adi F.
RA   Minna, John D.
RA   Myers, Jeffrey N.
RA   Lu, Yi-Ling
RA   Mills, Gordon B.
RA   Liang, Han
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   PubMed=31733513; DOI=10.1016/j.isci.2019.10.059; PMCID=PMC6889472;
RA   Guo, Tian-Nan
RA   Luna, Augustin
RA   Rajapakse, Vinodh N.
RA   Koh, Gene Ching-Chiek
RA   Wu, Zhi-Cheng
RA   Liu, Wei
RA   Sun, Yao-Ting
RA   Gao, Huan-Huan
RA   Menden, Michael Patrick
RA   Xu, Chao
RA   Calzone, Laurence
RA   Martignetti, Loredana
RA   Auwerx, Chiara
RA   Buljan, Marija
RA   Banaei-Esfahani, Amir
RA   Ori, Alessandro
RA   Iskar, Murat
RA   Gillet, Ludovic C.
RA   Bi, Ran
RA   Zhang, Jiang-Nan
RA   Zhang, Huan-Huan
RA   Yu, Chen-Huan
RA   Zhong, Qing
RA   Varma, Sudhir
RA   Schmitt, Uwe
RA   Qiu, Peng
RA   Zhang, Qiu-Shi
RA   Zhu, Yi
RA   Wild, Peter Johannes
RA   Garnett, Mathew J.
RA   Bork, Peer
RA   Beck, Martin
RA   Liu, Ke-Xin
RA   Saez-Rodriguez, Julio
RA   Elloumi, Fathi
RA   Reinhold, William C.
RA   Sander, Chris
RA   Pommier, Yves
RA   Aebersold, Ruedi
RT   "Quantitative proteome landscape of the NCI-60 cancer cell lines.";
RL   iScience 21:664-680(2019).
//
RX   PubMed=6933476; DOI=10.1073/pnas.77.7.4260; PMCID=PMC349812;
RA   Houghton, Alan N.
RA   Taormina, Michael C.
RA   Ikeda, Hisami
RA   Watanabe, Tadashi
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Serological survey of normal humans for natural antibody to cell
RT   surface antigens of melanoma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 77:4260-4264(1980).
//
RX   PubMed=2041050; DOI=10.1093/jnci/83.11.757;
RA   Monks, Anne
RA   Scudiero, Dominic A.
RA   Skehan, Philip
RA   Shoemaker, Robert H.
RA   Paull, Kenneth D.
RA   Vistica, David T.
RA   Hose, Curtis D.
RA   Langley, John
RA   Cronise, Paul
RA   Vaigro-Wolff, Anne
RA   Gray-Goodrich, Marcia
RA   Campbell, Hugh
RA   Mayo, Joseph G.
RA   Boyd, Michael R.
RT   "Feasibility of a high-flux anticancer drug screen using a diverse
RT   panel of cultured human tumor cell lines.";
RL   J. Natl. Cancer Inst. 83:757-766(1991).
//
RX   PubMed=23933261; DOI=10.1016/j.celrep.2013.07.018;
RA   Moghaddas Gholami, Amin
RA   Hahne, Hannes
RA   Wu, Zhi-Xiang
RA   Auer, Florian Johann
RA   Meng, Chen
RA   Wilhelm, Mathias
RA   Kuster, Bernhard
RT   "Global proteome analysis of the NCI-60 cell line panel.";
RL   Cell Rep. 4:609-620(2013).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878;
RA   Scholtalbers, Jelle
RA   Boegel, Sebastian
RA   Bukur, Thomas
RA   Byl, Marius
RA   Goerges, Sebastian
RA   Sorn, Patrick
RA   Loewer, Martin
RA   Sahin, Ugur
RA   Castle, John C.
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//
RX   PubMed=24576830; DOI=10.1158/0008-5472.CAN-13-2625; PMCID=PMC4005042;
RA   Nissan, Moriah Heller
RA   Pratilas, Christine A.
RA   Jones, Alexis M.
RA   Ramirez, Ricardo
RA   Won, Helen
RA   Liu, Cai-Lian
RA   Tiwari, Shakuntala
RA   Kong, Li
RA   Hanrahan, Aphrothiti J.
RA   Yao, Zhan
RA   Merghoub, Taha
RA   Ribas, Antoni
RA   Chapman, Paul B.
RA   Yaeger, Rona D.
RA   Taylor, Barry Stephen
RA   Schultz, Nikolaus
RA   Berger, Michael F.
RA   Rosen, Neal
RA   Solit, David B.
RT   "Loss of NF1 in cutaneous melanoma is associated with RAS activation
RT   and MEK dependence.";
RL   Cancer Res. 74:2340-2350(2014).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil, Julie
RA   Chen, Zhi-Hua
RA   Monteiro, Alvaro N.A.
RA   Teer, Jamie K.
RA   Eschrich, Steven A.
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=17516929; DOI=10.1111/j.1600-0749.2007.00375.x;
RA   Johansson, Peter
RA   Pavey, Sandra
RA   Hayward, Nicholas K.
RT   "Confirmation of a BRAF mutation-associated gene expression signature
RT   in melanoma.";
RL   Pigment Cell Res. 20:216-221(2007).
//
RX   PubMed=22347499; DOI=10.1371/journal.pone.0031628; PMCID=PMC3276511;
RA   Ruan, Xiao-Yang
RA   Kocher, Jean-Pierre A.
RA   Pommier, Yves
RA   Liu, Hong-Fang
RA   Reinhold, William C.
RT   "Mass homozygotes accumulation in the NCI-60 cancer cell lines as
RT   compared to HapMap trios, and relation to fragile site location.";
RL   PLoS ONE 7:e31628.1-e31628.9(2012).
//
RX   PubMed=26673621; DOI=10.18632/oncotarget.6548; PMCID=PMC4823068;
RA   Roller, Devin Grimm
RA   Capaldo, Brian J.
RA   Bekiranov, Stefan
RA   Mackey, Aaron J.
RA   Conaway, Mark Robert
RA   Petricoin, Emanuel F. 3rd
RA   Gioeli, Daniel
RA   Weber, Michael J.
RT   "Combinatorial drug screening and molecular profiling reveal diverse
RT   mechanisms of intrinsic and adaptive resistance to BRAF inhibition in
RT   V600E BRAF mutant melanomas.";
RL   Oncotarget 7:2734-2753(2016).
//
RX   PubMed=17363583; DOI=10.1158/0008-5472.CAN-06-4152;
RA   Stark, Mitchell S.
RA   Hayward, Nicholas K.
RT   "Genome-wide loss of heterozygosity and copy number analysis in
RT   melanoma using high-density single-nucleotide polymorphism arrays.";
RL   Cancer Res. 67:2632-2642(2007).
//
RX   PubMed=19372543; DOI=10.1158/1535-7163.MCT-08-0921; PMCID=PMC4020356;
RA   Lorenzi, Philip L.
RA   Reinhold, William C.
RA   Varma, Sudhir
RA   Hutchinson, Amy A.
RA   Pommier, Yves
RA   Chanock, Stephen Jacob
RA   Weinstein, John N.
RT   "DNA fingerprinting of the NCI-60 cell line panel.";
RL   Mol. Cancer Ther. 8:713-724(2009).
//
RX   PubMed=14692828; DOI=10.1290/1543-706X(2004)40<35:COHMCL>2.0.CO;2;
RA   Quinones, Luis G.
RA   Garcia-Castro, Ivette
RT   "Characterization of human melanoma cell lines according to their
RT   migratory properties in vitro.";
RL   In Vitro Cell. Dev. Biol. Anim. 40:35-42(2004).
//
RX   PubMed=18277095; DOI=10.4161/cbt.7.5.5712;
RA   Berglind, Hanna
RA   Pawitan, Yudi
RA   Kato, Shunsuke
RA   Ishioka, Chikashi
RA   Soussi, Thierry
RT   "Analysis of p53 mutation status in human cancer cell lines: a
RT   paradigm for cell line cross-contamination.";
RL   Cancer Biol. Ther. 7:699-708(2008).
//
RX   PubMed=7718330; DOI=10.1016/0959-8049(94)00472-H;
RA   Baguley, Bruce Charles
RA   Marshall, Elaine S.
RA   Whittaker, John Richard
RA   Dotchin, M.C.
RA   Nixon, Johanna
RA   McCrystal, Michael R.
RA   Finlay, Graeme John
RA   Matthews, John H.L.
RA   Holdaway, Karen M.
RA   van Zijl, Pierre Leonardus
RT   "Resistance mechanisms determining the in vitro sensitivity to
RT   paclitaxel of tumour cells cultured from patients with ovarian
RT   cancer.";
RL   Eur. J. Cancer 31A:230-237(1995).
//
RX   PubMed=12068308; DOI=10.1038/nature00766;
RA   Davies, Helen R.
RA   Bignell, Graham Robert
RA   Cox, Charles
RA   Stephens, Philip J.
RA   Edkins, Sarah
RA   Clegg, Sheila
RA   Teague, Jon W.
RA   Woffendin, Hayley
RA   Garnett, Mathew J.
RA   Bottomley, William
RA   Davis, Neil
RA   Dicks, Ed
RA   Ewing, Rebecca
RA   Floyd, Yvonne
RA   Gray, Kristian
RA   Hall, Sarah
RA   Hawes, Rachel
RA   Hughes, Jaime
RA   Kosmidou, Vivian
RA   Menzies, Andrew
RA   Mould, Catherine
RA   Parker, Adrian
RA   Stevens, Claire
RA   Watt, Stephen
RA   Hooper, Steven
RA   Wilson, Rebecca
RA   Jayatilake, Hiran
RA   Gusterson, Barry Austin
RA   Cooper, Colin S.
RA   Shipley, Janet M.
RA   Hargrave, Darren
RA   Pritchard-Jones, Kathryn
RA   Maitland, Norman J.
RA   Chenevix-Trench, Georgia
RA   Riggins, Gregory J.
RA   Bigner, Darell Doty
RA   Palmieri, Giuseppe
RA   Cossu, Antonio
RA   Flanagan, Adrienne Margaret
RA   Nicholson, Andrew
RA   Ho, Judy W.C.
RA   Leung, Suet Yi
RA   Yuen, Siu Tsan
RA   Weber, Barbara L.
RA   Seigler, Hilliard Foster
RA   Darrow, Timothy L.
RA   Paterson, Hugh F.
RA   Marais, Richard
RA   Marshall, Christopher John
RA   Wooster, Richard
RA   Stratton, Michael Rudolf
RA   Futreal, P. Andrew
RT   "Mutations of the BRAF gene in human cancer.";
RL   Nature 417:949-954(2002).
//
RX   PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254;
RA   Nusinow, David Paul
RA   Szpyt, John
RA   Ghandi, Mahmoud
RA   Rose, Christopher M.
RA   McDonald, E. Robert 3rd
RA   Kalocsay, Marian
RA   Jane-Valbuena, Judit
RA   Gelfand, Ellen T.
RA   Schweppe, Devin Karl
RA   Jedrychowski, Mark P.
RA   Golji, Javad
RA   Porter, Dale A.
RA   Rejtar, Tomas
RA   Wang, Y. Karen
RA   Kryukov, Gregory V.
RA   Stegmeier, Frank
RA   Erickson, Brian K.
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RA   Gygi, Steven P.
RT   "Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
RL   Cell 180:387-402.e16(2020).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh, Jorgen
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=10766161;
RA   Tsao, Hensin
RA   Zhang, Xue
RA   Fowlkes, Kianna
RA   Haluska, Frank G.
RT   "Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous
RT   melanoma cell lines.";
RL   Cancer Res. 60:1800-1804(2000).
//
RX   PubMed=12479222;
RA   Wahl, Miriam L.
RA   Owen, Judith A.
RA   Burd, Randy
RA   Herlands, Robin A.
RA   Nogami, Suzanne Sayake
RA   Rodeck, Ulrich
RA   Berd, David
RA   Leeper, Dennis Burton
RA   Owen, Charles S.
RT   "Regulation of intracellular pH in human melanoma: potential
RT   therapeutic implications.";
RL   Mol. Cancer Ther. 1:617-628(2002).
//
RX   PubMed=19799798; DOI=10.1186/1471-2407-9-352; PMCID=PMC2763007;
RA   Casula, Milena
RA   Muggiano, Antonio
RA   Cossu, Antonio
RA   Budroni, Mario
RA   Caraco, Corrado
RA   Ascierto, Paolo Antonio
RA   Pagani, Elena
RA   Stanganelli, Ignazio
RA   Canzanella, Sergio
RA   Sini, Maria Cristina
RA   Palomba, Grazia
RA   Palmieri, Giuseppe
RG   Italian Melanoma Intergroup (IMI);
RT   "Role of key-regulator genes in melanoma susceptibility and
RT   pathogenesis among patients from South Italy.";
RL   BMC Cancer 9:352.1-352.11(2009).
//
RX   PubMed=20406486; DOI=10.1186/1479-5876-8-39; PMCID=PMC2876068;
RA   Sondergaard, Jonas Norskov
RA   Nazarian, Ramin
RA   Wang, Qi
RA   Guo, De-Liang
RA   Hsueh, Teli
RA   Mok, Stephen
RA   Sazegar, Hooman
RA   MacConaill, Laura Eleanor
RA   Barretina, Jordi Ginesta
RA   Kehoe, Sarah M.
RA   Attar, Narsis
RA   von Euw, Erika Maria
RA   Zuckerman, Jonathan E.
RA   Chmielowski, Bartosz
RA   Comin-Anduix, Begonya
RA   Koya, Richard C.
RA   Mischel, Paul Salomon
RA   Lo, Roger S.
RA   Ribas, Antoni
RT   "Differential sensitivity of melanoma cell lines with BRAFV600E
RT   mutation to the specific Raf inhibitor PLX4032.";
RL   J. Transl. Med. 8:39.1-39.11(2010).
//
RX   PubMed=22384151; DOI=10.1371/journal.pone.0032096; PMCID=PMC3285665;
RA   Lee, Jun-Seok
RA   Kim, Yun Kyung
RA   Kim, Han Jo
RA   Hajar, Siti
RA   Tan, Yee Ling
RA   Kang, Nam-Young
RA   Ng, Shin Hui
RA   Yoon, Chang No
RA   Chang, Young-Tae
RT   "Identification of cancer cell-line origins using fluorescence
RT   image-based phenomic screening.";
RL   PLoS ONE 7:e32096.1-e32096.8(2012).
//
RX   PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209;
RA   Hogan, Kevin T.
RA   Coppola, Michael A.
RA   Gatlin, Christine L.
RA   Thompson, Lee W.
RA   Shabanowitz, Jeffrey
RA   Hunt, Donald Frederick
RA   Engelhard, Victor H.
RA   Ross, Mark M.
RA   Slingluff, Craig L. Jr.
RT   "Identification of novel and widely expressed cancer/testis gene
RT   isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to
RT   melanoma.";
RL   Cancer Res. 64:1157-1163(2004).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103;
RA   Ghandi, Mahmoud
RA   Huang, Franklin W.
RA   Jane-Valbuena, Judit
RA   Kryukov, Gregory V.
RA   Lo, Christopher C.
RA   McDonald, E. Robert 3rd
RA   Barretina, Jordi Ginesta
RA   Gelfand, Ellen T.
RA   Bielski, Craig M.
RA   Li, Hao-Xin
RA   Hu, Kevin
RA   Andreev-Drakhlin, Alexander Y.
RA   Kim, Jaegil
RA   Hess, Julian M.
RA   Haas, Brian J.
RA   Aguet, Francois
RA   Weir, Barbara A.
RA   Rothberg, Michael V.
RA   Paolella, Brenton R.
RA   Lawrence, Michael Scott
RA   Akbani, Rehan
RA   Lu, Yi-Ling
RA   Tiv, Hong L.
RA   Gokhale, Prafulla C.
RA   de Weck, Antoine
RA   Mansour, Ali Amin
RA   Oh, Coyin
RA   Shih, Juliann
RA   Hadi, Kevin
RA   Rosen, Yanay
RA   Bistline, Jonathan
RA   Venkatesan, Kavitha
RA   Reddy, Anupama
RA   Sonkin, Dmitriy
RA   Liu, Manway
RA   Lehar, Joseph
RA   Korn, Joshua M.
RA   Porter, Dale A.
RA   Jones, Michael D.
RA   Golji, Javad
RA   Caponigro, Giordano
RA   Taylor, Jordan E.
RA   Dunning, Caitlin M.
RA   Creech, Amanda L.
RA   Warren, Allison C.
RA   McFarland, James M.
RA   Zamanighomi, Mahdi
RA   Kauffmann, Audrey
RA   Stransky, Nicolas
RA   Imielinski, Marcin
RA   Maruvka, Yosef E.
RA   Cherniack, Andrew D.
RA   Tsherniak, Aviad
RA   Vazquez, Francisca
RA   Jaffe, Jacob D.
RA   Lane, Andrew Alan
RA   Weinstock, David M.
RA   Johannessen, Cory M.
RA   Morrissey, Michael P.
RA   Stegmeier, Frank
RA   Schlegel, Robert
RA   Hahn, William Chun
RA   Getz, Gad
RA   Mills, Gordon B.
RA   Boehm, Jesse S.
RA   Golub, Todd Robert
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//
RX   PubMed=24279929; DOI=10.1186/2049-3002-1-20; PMCID=PMC4178206;
RA   Dolfi, Sonia C.
RA   Chan, Leo Li-Ying
RA   Qiu, Jean
RA   Tedeschi, Philip M.
RA   Bertino, Joseph Rocco
RA   Hirshfield, Kim Marie
RA   Oltvai, Zoltan Nagy
RA   Vazquez, Alexei
RT   "The metabolic demands of cancer cells are coupled to their size and
RT   protein synthesis rates.";
RL   Cancer Metab. 1:20.1-20.13(2013).
//
RX   PubMed=9331090;
RA   O'Connor, Patrick M.
RA   Jackman, Joany
RA   Bae, Insoo
RA   Myers, Timothy Gene
RA   Fan, Sai-Jun
RA   Mutoh, Masato
RA   Scudiero, Dominic A.
RA   Monks, Anne
RA   Sausville, Edward A.
RA   Weinstein, John N.
RA   Friend, Stephen H.
RA   Fornace, Albert J. Jr.
RA   Kohn, Kurt W.
RT   "Characterization of the p53 tumor suppressor pathway in cell lines of
RT   the National Cancer Institute anticancer drug screen and correlations
RT   with the growth-inhibitory potency of 123 anticancer agents.";
RL   Cancer Res. 57:4285-4300(1997).
//
RX   PubMed=17088437; DOI=10.1158/1535-7163.MCT-06-0433; PMCID=PMC2705832;
RA   Ikediobi, Ogechi N.
RA   Davies, Helen R.
RA   Bignell, Graham Robert
RA   Edkins, Sarah
RA   Stevens, Claire
RA   O'Meara, Sarah
RA   Santarius, Thomas
RA   Avis, Tim
RA   Barthorpe, Syd
RA   Brackenbury, Lisa
RA   Buck, Gemma
RA   Butler, Adam P.
RA   Clements, Jody
RA   Cole, Jennifer
RA   Dicks, Ed
RA   Forbes, Simon
RA   Gray, Kristian
RA   Halliday, Kelly
RA   Harrison, Rachel
RA   Hills, Katy
RA   Hinton, Jonathan
RA   Hunter, Chris
RA   Jenkinson, Andy
RA   Jones, David
RA   Kosmidou, Vivian
RA   Lugg, Richard
RA   Menzies, Andrew
RA   Mironenko, Tatiana
RA   Parker, Adrian
RA   Perry, Janet
RA   Raine, Keiran Martin
RA   Richardson, David
RA   Shepherd, Rebecca
RA   Small, Alex
RA   Smith, Raffaella
RA   Solomon, Helen
RA   Stephens, Philip J.
RA   Teague, Jon W.
RA   Tofts, Calli
RA   Varian, Jennifer
RA   Webb, Tony
RA   West, Sofie
RA   Widaa, Sara
RA   Yates, Andy
RA   Reinhold, William C.
RA   Weinstein, John N.
RA   Stratton, Michael Rudolf
RA   Futreal, P. Andrew
RA   Wooster, Richard
RT   "Mutation analysis of 24 known cancer genes in the NCI-60 cell line
RT   set.";
RL   Mol. Cancer Ther. 5:2606-2612(2006).
//
RX   PubMed=17308088; DOI=10.1158/0008-5472.CAN-06-3311;
RA   Shields, Janiel M.
RA   Thomas, Nancy E.
RA   Cregger, Melissa
RA   Berger, Aaron J.
RA   Leslie, Michael
RA   Torrice, Chad
RA   Hao, Hong-Lin
RA   Penland, Shannon
RA   Arbiser, Jack Leonard
RA   Scott, Glynis A.
RA   Zhou, Tong
RA   Bar-Eli, Menashe
RA   Bear, James E.
RA   Der, Channing Joseph
RA   Kaufmann, William K.
RA   Rimm, David Laurence
RA   Sharpless, Norman Edward
RT   "Lack of extracellular signal-regulated kinase mitogen-activated
RT   protein kinase signaling shows a new type of melanoma.";
RL   Cancer Res. 67:1502-1512(2007).
//
RX   PubMed=23285177; DOI=10.1371/journal.pone.0052760; PMCID=PMC3532357;
RA   Schayowitz, Adam B.
RA   Bertenshaw, Greg P.
RA   Jeffries, Emiko
RA   Schatz, Timothy
RA   Cotton, James
RA   Villanueva, Jessie
RA   Herlyn, Meenhard
RA   Krepler, Clemens
RA   Vultur, Adina
RA   Xu, Wei
RA   Yu, Gordon H.
RA   Schuchter, Lynn Mara
RA   Clark, Douglas P.
RT   "Functional profiling of live melanoma samples using a novel automated
RT   platform.";
RL   PLoS ONE 7:e52760.1-e52760.8(2012).
//
RX   PubMed=7017212; DOI=10.1093/jnci/66.6.1003;
RA   Pollack, Marilyn S.
RA   Heagney, Socorro D.
RA   Livingston, Philip O.
RA   Fogh, Jorgen
RT   "HLA-A, B, C and DR alloantigen expression on forty-six cultured human
RT   tumor cell lines.";
RL   J. Natl. Cancer Inst. 66:1003-1012(1981).
//
RX   PubMed=2983346; DOI=10.1073/pnas.82.5.1470; PMCID=PMC397284;
RA   Dracopoli, Nicholas C.
RA   Houghton, Alan N.
RA   Old, Lloyd John
RT   "Loss of polymorphic restriction fragments in malignant melanoma:
RT   implications for tumor heterogeneity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:1470-1474(1985).
//
RX   PubMed=3335022;
RA   Alley, Michael Curtis
RA   Scudiero, Dominic A.
RA   Monks, Anne
RA   Hursey, Miriam L.
RA   Czerwinski, Maciej J.
RA   Fine, Donald L.
RA   Abbott, Betty Jane
RA   Mayo, Joseph G.
RA   Shoemaker, Robert H.
RA   Boyd, Michael R.
RT   "Feasibility of drug screening with panels of human tumor cell lines
RT   using a microculture tetrazolium assay.";
RL   Cancer Res. 48:589-601(1988).
//
RX   PubMed=9466661; DOI=10.1002/(SICI)1097-0215(19980209)75:4<590::AID-IJC16>3.0.CO;2-D;
RA   White, Christine A.
RA   Thomson, Scott A.
RA   Cooper, Leanne T.
RA   van Endert, Peter M.
RA   Tampe, Robert
RA   Coupar, Barbara
RA   Qiu, Li
RA   Parsons, Peter G.
RA   Moss, Denis J.
RA   Khanna, Rajiv
RT   "Constitutive transduction of peptide transporter and HLA genes
RT   restores antigen processing function and cytotoxic T cell-mediated
RT   immune recognition of human melanoma cells.";
RL   Int. J. Cancer 75:590-595(1998).
//
RX   PubMed=11016658;
RA   Girnita, Leonard
RA   Girnita, Ada
RA   Brodin, Bertha
RA   Xie, Yun-Tao
RA   Nilsson, Gunnar
RA   Dricu, Anica
RA   Lundeberg, Joakim
RA   Wejde, Johan
RA   Bartolazzi, Armando
RA   Wiman, Klas G.
RA   Larsson, Olle
RT   "Increased expression of insulin-like growth factor I receptor in
RT   malignant cells expressing aberrant p53: functional impact.";
RL   Cancer Res. 60:5278-5283(2000).
//
RX   PubMed=8631022;
RA   Bae, Insoo
RA   Smith, Martin L.
RA   Sheikh, M. Saeed
RA   Zhan, Qi-Min
RA   Scudiero, Dominic A.
RA   Friend, Stephen H.
RA   O'Connor, Patrick M.
RA   Fornace, Albert J. Jr.
RT   "An abnormality in the p53 pathway following gamma-irradiation in many
RT   wild-type p53 human melanoma lines.";
RL   Cancer Res. 56:840-847(1996).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn, Christiaan
RA   Durinck, Steffen
RA   Stawiski, Eric W.
RA   Haverty, Peter M.
RA   Jiang, Zhao-Shi
RA   Liu, Han-Bin
RA   Degenhardt, Jeremiah
RA   Mayba, Oleg
RA   Gnad, Florian
RA   Liu, Jin-Feng
RA   Pau, Gregoire
RA   Reeder, Jens
RA   Cao, Yi
RA   Mukhyala, Kiran
RA   Selvaraj, Suresh K.
RA   Yu, Ma-Mie
RA   Zynda, Gregory J.
RA   Brauer, Matthew J.
RA   Wu, Thomas D.
RA   Gentleman, Robert Clifford
RA   Manning, Gerard
RA   Yauch, Robert L.
RA   Bourgon, Richard
RA   Stokoe, David
RA   Modrusan, Zora
RA   Neve, Richard M.
RA   de Sauvage, Frederic J.
RA   Settleman, Jeffrey
RA   Seshagiri, Somasekar
RA   Zhang, Ze-Min
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=30674989; DOI=10.1038/s41388-018-0640-2; PMCID=PMC6563616;
RA   Mancuso, Pietro
RA   Tricarico, Rossella
RA   Bhattacharjee, Vikram
RA   Cosentino, Laura
RA   Kadariya, Yuwaraj
RA   Jelinek, Jaroslav
RA   Nicolas, Emmanuelle
RA   Einarson, Margret
RA   Beeharry, Neil
RA   Devarajan, Karthik
RA   Katz, Richard A.
RA   Dorjsuren, Dorjbal G.
RA   Sun, Hong-Mao
RA   Simeonov, Anton
RA   Giordano, Antonio
RA   Testa, Joseph R.
RA   Davidson, Guillaume
RA   Davidson, Irwin
RA   Larue, Lionel
RA   Sobol, Robert William
RA   Yen, Timothy J.
RA   Bellacosa, Alfonso
RT   "Thymine DNA glycosylase as a novel target for melanoma.";
RL   Oncogene 38:3710-3728(2019).
//
RX   PubMed=978138; DOI=10.1084/jem.144.4.873; PMCID=PMC2190439;
RA   Shiku, Hiroshi
RA   Takahashi, Toshitada
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Cell surface antigens of human malignant melanoma. II. Serological
RT   typing with immune adherence assays and definition of two new surface
RT   antigens.";
RL   J. Exp. Med. 144:873-881(1976).
//
RX   DOI=10.1007/978-1-4615-7228-2_39;
RA   Houghton, Alan N.
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Malignant melanoma. Current status of the search for melanoma-specific
RT   antigens.";
RL   (In book chapter) Immunodermatology. Comprehensive Immunology, Vol 7; Safai, Bijan & Good, Robert Alan (eds.); pp.557-576; Springer; Boston; USA (1981).
//
RX   PubMed=1067619; DOI=10.1073/pnas.73.9.3278; PMCID=PMC431008;
RA   Carey, Thomas E.
RA   Takahashi, Toshitada
RA   Resnick-Silverman, Lois A.
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Cell surface antigens of human malignant melanoma: mixed
RT   hemadsorption assays for humoral immunity to cultured autologous
RT   melanoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 73:3278-3282(1976).
//
RX   PubMed=1716514;
RA   Albino, Anthony P.
RA   Davis, Brigid M.
RA   Nanus, David Michael
RT   "Induction of growth factor RNA expression in human malignant
RT   melanoma: markers of transformation.";
RL   Cancer Res. 51:4815-4820(1991).
//
RX   PubMed=7175440; DOI=10.1084/jem.156.6.1755; PMCID=PMC2186870;
RA   Houghton, Alan N.
RA   Eisinger, Magdalena
RA   Albino, Anthony P.
RA   Cairncross, J. Gregory
RA   Old, Lloyd John
RT   "Surface antigens of melanocytes and melanomas. Markers of melanocyte
RT   differentiation and melanoma subsets.";
RL   J. Exp. Med. 156:1755-1766(1982).
//
RX   PubMed=15467732; DOI=10.1038/sj.onc.1208152;
RA   Tanami, Hideaki
RA   Imoto, Issei
RA   Hirasawa, Akira
RA   Yuki, Yasuhiro
RA   Sonoda, Itaru
RA   Inoue, Jun
RA   Yasui, Kohichiroh
RA   Misawa-Furihata, Akiko
RA   Kawakami, Yutaka
RA   Inazawa, Johji
RT   "Involvement of overexpressed wild-type BRAF in the growth of
RT   malignant melanoma cell lines.";
RL   Oncogene 23:8796-8804(2004).
//
RX   PubMed=9354451;
RA   Castellano, Marina
RA   Pollock, Pamela M.
RA   Walters, Marilyn K.
RA   Sparrow, Louise E.
RA   Down, Louise M.
RA   Gabrielli, Brian G.
RA   Parsons, Peter G.
RA   Hayward, Nicholas K.
RT   "CDKN2A/p16 is inactivated in most melanoma cell lines.";
RL   Cancer Res. 57:4868-4875(1997).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775;
RA   Goncalves, Emanuel
RA   Poulos, Rebecca C.
RA   Cai, Zhao-Xiang
RA   Barthorpe, Syd
RA   Manda, Srikanth S.
RA   Lucas, Natasha
RA   Beck, Alexandra
RA   Bucio-Noble, Daniel
RA   Dausmann, Michael
RA   Hall, Caitlin
RA   Hecker, Michael
RA   Koh, Jennifer
RA   Lightfoot, Howard
RA   Mahboob, Sadia
RA   Mali, Iman
RA   Morris, James
RA   Richardson, Laura
RA   Seneviratne, Akila J.
RA   Shepherd, Rebecca
RA   Sykes, Erin
RA   Thomas, Frances
RA   Valentini, Sara
RA   Williams, Steven G.
RA   Wu, Yang-Xiu
RA   Xavier, Dylan
RA   MacKenzie, Karen L.
RA   Hains, Peter G.
RA   Tully, Brett
RA   Robinson, Phillip James
RA   Zhong, Qing
RA   Garnett, Mathew J.
RA   Reddel, Roger Robert
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=27087056; DOI=10.1038/srep24569; PMCID=PMC4834532;
RA   Haridas, Parvathi
RA   McGovern, Jacqui A.
RA   Kashyap, Abhishek S.
RA   McElwain, Donald Leon Sean
RA   Simpson, Matthew J.
RT   "Standard melanoma-associated markers do not identify the MM127
RT   metastatic melanoma cell line.";
RL   Sci. Rep. 6:24569.1-24569.6(2016).
//
RX   PubMed=2068080; DOI=10.1073/pnas.88.14.6028; PMCID=PMC52015;
RA   Cornil, Isabelle
RA   Theodorescu, Dan
RA   Man, Shan
RA   Herlyn, Meenhard
RA   Jambrosic, Jadranka Adriana
RA   Kerbel, Robert S.
RT   "Fibroblast cell interactions with human melanoma cells affect tumor
RT   cell growth as a function of tumor progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6028-6032(1991).
//
RX   PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027;
RA   Barretina, Jordi Ginesta
RA   Caponigro, Giordano
RA   Stransky, Nicolas
RA   Venkatesan, Kavitha
RA   Margolin, Adam A.
RA   Kim, Sungjoon
RA   Wilson, Christopher J.
RA   Lehar, Joseph
RA   Kryukov, Gregory V.
RA   Sonkin, Dmitriy
RA   Reddy, Anupama
RA   Liu, Manway
RA   Murray, Lauren
RA   Berger, Michael F.
RA   Monahan, John E.
RA   Morais, Paula
RA   Meltzer, Jodi
RA   Korejwa, Adam
RA   Jane-Valbuena, Judit
RA   Mapa, Felipa A.
RA   Thibault, Joseph
RA   Bric-Furlong, Eva
RA   Raman, Pichai
RA   Shipway, Aaron
RA   Engels, Ingo H.
RA   Cheng, Jill
RA   Yu, Guo-Ying K.
RA   Yu, Jian-Jun
RA   Aspesi, Peter Jr.
RA   de Silva, Melanie
RA   Jagtap, Kalpana
RA   Jones, Michael D.
RA   Wang, Li
RA   Hatton, Charles
RA   Palescandolo, Emanuele
RA   Gupta, Supriya
RA   Mahan, Scott
RA   Sougnez, Carrie
RA   Onofrio, Robert C.
RA   Liefeld, Ted
RA   MacConaill, Laura Eleanor
RA   Winckler, Wendy
RA   Reich, Michael
RA   Li, Nan-Xin
RA   Mesirov, Jill P.
RA   Gabriel, Stacey B.
RA   Getz, Gad
RA   Ardlie, Kristin
RA   Chan, Vivien
RA   Myer, Vic E.
RA   Weber, Barbara L.
RA   Porter, Jeff
RA   Warmuth, Markus
RA   Finan, Peter
RA   Harris, Jennifer L.
RA   Meyerson, Matthew Langer
RA   Golub, Todd Robert
RA   Morrissey, Michael P.
RA   Sellers, William Raj
RA   Schlegel, Robert
RA   Garraway, Levi Alexander
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=313568; DOI=10.1073/pnas.76.6.2898; PMCID=PMC383717;
RA   Carey, Thomas E.
RA   Lloyd, Kenneth Oliver
RA   Takahashi, Toshitada
RA   Travassos, Luiz Rodolpho
RA   Old, Lloyd John
RT   "AU cell-surface antigen of human malignant melanoma: solubilization
RT   and partial characterization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:2898-2902(1979).
//
RX   PubMed=24670534; DOI=10.1371/journal.pone.0092047; PMCID=PMC3966786;
RA   Varma, Sudhir
RA   Pommier, Yves
RA   Sunshine, Margot
RA   Weinstein, John N.
RA   Reinhold, William C.
RT   "High resolution copy number variation data in the NCI-60 cancer cell
RT   lines from whole genome microarrays accessible through CellMiner.";
RL   PLoS ONE 9:e92047.1-e92047.15(2014).
//
RX   PubMed=21725359; DOI=10.1038/onc.2011.250; PMCID=PMC3267014;
RA   Xing, Feng
RA   Persaud, Yogindra
RA   Pratilas, Christine A.
RA   Taylor, Barry Stephen
RA   Janakiraman, Manickam
RA   She, Qing-Bai
RA   Gallardo, Humilidad F.
RA   Liu, Cai-Lian
RA   Merghoub, Taha
RA   Hefter, Blake E.
RA   Dolgalev, Igor
RA   Viale, Agnes J.
RA   Heguy, Adriana
RA   de Stanchina, Elisa
RA   Cobrinik, David
RA   Bollag, Gideon
RA   Wolchok, Jedd David
RA   Houghton, Alan N.
RA   Solit, David B.
RT   "Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF
RT   dependence in melanomas harboring (V600E)BRAF.";
RL   Oncogene 31:446-457(2012).
//
RX   PubMed=27377824; DOI=10.1038/sdata.2016.52; PMCID=PMC4932877;
RA   Mestdagh, Pieter
RA   Lefever, Steve
RA   Volders, Pieter-Jan
RA   Derveaux, Stefaan
RA   Hellemans, Jan
RA   Vandesompele, Jo
RT   "Long non-coding RNA expression profiling in the NCI60 cancer cell
RT   line panel using high-throughput RT-qPCR.";
RL   Sci. Data 3:160052.1-160052.6(2016).
//
RX   PubMed=27807467; DOI=10.1186/s13100-016-0078-4; PMCID=PMC5087121;
RA   Zampella, John G.
RA   Rodic, Nemanja
RA   Yang, Wan Rou
RA   Huang, Cheng Ran Lisa
RA   Welch, Jane
RA   Gnanakkan, Veena P.
RA   Cornish, Toby Charles
RA   Boeke, Jef D.
RA   Burns, Kathleen H.
RT   "A map of mobile DNA insertions in the NCI-60 human cancer cell
RT   panel.";
RL   Mob. DNA 7:20.1-20.11(2016).
//
RX   PubMed=6197381; DOI=10.1002/ijc.2910320610;
RA   Mattes, Michael Jules
RA   Thomson, Timothy M.
RA   Old, Lloyd John
RA   Lloyd, Kenneth Oliver
RT   "A pigmentation-associated, differentiation antigen of human melanoma
RT   defined by a precipitating antibody in human serum.";
RL   Int. J. Cancer 32:717-721(1983).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469;
RA   Iorio, Francesco
RA   Knijnenburg, Theo A.
RA   Vis, Daniel J.
RA   Bignell, Graham Robert
RA   Menden, Michael Patrick
RA   Schubert, Michael
RA   Aben, Nanne
RA   Goncalves, Emanuel
RA   Barthorpe, Syd
RA   Lightfoot, Howard
RA   Cokelaer, Thomas
RA   Greninger, Patricia
RA   van Dyk, Ewald
RA   Chang, Han
RA   de Silva, Heshani
RA   Heyn, Holger
RA   Deng, Xian-Ming
RA   Egan, Regina K.
RA   Liu, Qing-Song
RA   Mironenko, Tatiana
RA   Mitropoulos, Xeni
RA   Richardson, Laura
RA   Wang, Jin-Hua
RA   Zhang, Ting-Hu
RA   Moran, Sebastian
RA   Sayols, Sergi
RA   Soleimani, Maryam
RA   Tamborero, David
RA   Lopez-Bigas, Nuria
RA   Ross-Macdonald, Petra
RA   Esteller, Manel
RA   Gray, Nathanael S.
RA   Haber, Daniel Arie
RA   Stratton, Michael Rudolf
RA   Benes, Cyril Henri
RA   Wessels, Lodewyk F.A.
RA   Saez-Rodriguez, Julio
RA   McDermott, Ultan
RA   Garnett, Mathew J.
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=20041153; DOI=10.1371/journal.pone.0008461; PMCID=PMC2794539;
RA   Jeffs, Aaron R.
RA   Glover, Amy C.
RA   Slobbe, Lynn J.
RA   Wang, Li
RA   He, Shu-Jie
RA   Hazlett, Jody A.
RA   Awasthi, Anshul
RA   Woolley, Adele G.
RA   Marshall, Elaine S.
RA   Joseph, Wayne R.
RA   Print, Cristin Gregor
RA   Baguley, Bruce Charles
RA   Eccles, Michael R.
RT   "A gene expression signature of invasive potential in metastatic
RT   melanoma cells.";
RL   PLoS ONE 4:e8461.1-e8461.11(2009).
//
RX   PubMed=6864164; DOI=10.1084/jem.158.1.53; PMCID=PMC2187084;
RA   Houghton, Alan N.
RA   Brooks, Hannah
RA   Cote, Richard J.
RA   Taormina, Michael C.
RA   Oettgen, Herbert Friedrich
RA   Old, Lloyd John
RT   "Detection of cell surface and intracellular antigens by human
RT   monoclonal antibodies. Hybrid cell lines derived from lymphocytes of
RT   patients with malignant melanoma.";
RL   J. Exp. Med. 158:53-65(1983).
//
RX   PubMed=17260012; DOI=10.1038/sj.onc.1210252;
RA   Jonsson, Goran
RA   Dahl, Christina
RA   Staaf, Johan
RA   Sandberg, Troy
RA   Bendahl, Par-Ola
RA   Ringner, Markus
RA   Guldberg, Per
RA   Borg, Ake
RT   "Genomic profiling of malignant melanoma using tiling-resolution
RT   arrayCGH.";
RL   Oncogene 26:4738-4748(2007).
//
RX   PubMed=23856246; DOI=10.1158/0008-5472.CAN-12-3342; PMCID=PMC4893961;
RA   Abaan, Ogan Demir
RA   Polley, Eric C.
RA   Davis, Sean R.
RA   Zhu, Yue-Lin J.
RA   Bilke, Sven
RA   Walker, Robert L.
RA   Pineda, Marbin A.
RA   Gindin, Yevgeniy
RA   Jiang, Yuan
RA   Reinhold, William C.
RA   Holbeck, Susan L.
RA   Simon, Richard M.
RA   Doroshow, James H.
RA   Pommier, Yves
RA   Meltzer, Paul S.
RT   "The exomes of the NCI-60 panel: a genomic resource for cancer biology
RT   and systems pharmacology.";
RL   Cancer Res. 73:4372-4382(2013).
//
RX   PubMed=7999427; DOI=10.1016/0959-8049(94)90188-0;
RA   Marshall, Elaine S.
RA   Matthews, John H.L.
RA   Shaw, James H.F.
RA   Nixon, Johanna
RA   Tumewu, Paul
RA   Finlay, Graeme John
RA   Holdaway, Karen M.
RA   Baguley, Bruce Charles
RT   "Radiosensitivity of new and established human melanoma cell lines:
RT   comparison of [3H]thymidine incorporation and soft agar clonogenic
RT   assays.";
RL   Eur. J. Cancer 30A:1370-1376(1994).
//
RX   PubMed=6349783; DOI=10.1002/1097-0142(19830915)52:6<949::AID-CNCR2820520602>3.0.CO;2-2;
RA   Dantas, Mary E.
RA   Brown, Joseph P.
RA   Thomas, Mathew Roy
RA   Robinson, William A.
RA   Glode, L. Michael
RT   "Detection of melanoma cells in bone marrow using monoclonal
RT   antibodies. A comparison of fluorescence activated cell sorting (FACS)
RT   and conventional immunofluorescence (IF).";
RL   Cancer 52:949-953(1983).
//
RX   PubMed=38861359; DOI=10.1158/0008-5472.CAN-23-3031; PMCID=PMC11292194;
RA   Kunkel, Mark W.
RA   Coussens, Nathan P.
RA   Morris, Joel
RA   Taylor, Ronald C.
RA   Dexheimer, Thomas S.
RA   Jones, Eric M.
RA   Doroshow, James H.
RA   Teicher, Beverly A.
RT   "HTS384 NCI60: the next phase of the NCI60 screen.";
RL   Cancer Res. 84:2403-2416(2024).
//
RX   PubMed=21424129; DOI=10.3892/or.2011.1220;
RA   Manca, Antonella
RA   Sini, Maria Cristina
RA   Izzo, Francesco
RA   Ascierto, Paolo Antonio
RA   Tatangelo, Fabiana
RA   Botti, Gerardo
RA   Gentilcore, Giusy
RA   Capone, Marilena
RA   Mozzillo, Nicola
RA   Rozzo, Carla
RA   Cossu, Antonio
RA   Tanda, Francesco
RA   Palmieri, Giuseppe
RT   "Induction of arginosuccinate synthetase (ASS) expression affects the
RT   antiproliferative activity of arginine deiminase (ADI) in melanoma
RT   cells.";
RL   Oncol. Rep. 25:1495-1502(2011).
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell, Graham Robert
RA   Greenman, Christopher D.
RA   Davies, Helen R.
RA   Butler, Adam P.
RA   Edkins, Sarah
RA   Andrews, Jenny M.
RA   Buck, Gemma
RA   Chen, Lina
RA   Beare, David
RA   Latimer, Calli
RA   Widaa, Sara
RA   Hinton, Jonathan
RA   Fahey, Ciara
RA   Fu, Bei-Yuan
RA   Swamy, Sajani
RA   Dalgliesh, Gillian L.
RA   Teh, Bin Tean
RA   Deloukas, Panos
RA   Yang, Feng-Tang
RA   Campbell, Peter J.
RA   Futreal, P. Andrew
RA   Stratton, Michael Rudolf
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=327080; DOI=10.1093/jnci/59.1.221;
RA   Fogh, Jorgen
RA   Fogh, Jens M.
RA   Orfeo, Thomas
RT   "One hundred and twenty-seven cultured human tumor cell lines
RT   producing tumors in nude mice.";
RL   J. Natl. Cancer Inst. 59:221-226(1977).
//
RX   PubMed=15748285; DOI=10.1186/1479-5876-3-11; PMCID=PMC555742;
RA   Adams, Sharon
RA   Robbins, Fu-Meei
RA   Chen, Deborah
RA   Wagage, Devika
RA   Holbeck, Susan L.
RA   Morse, Herbert Carpenter 3rd
RA   Stroncek, David
RA   Marincola, Francesco M.
RT   "HLA class I and II genotype of the NCI-60 cell lines.";
RL   J. Transl. Med. 3:11.1-11.8(2005).
//
RX   PubMed=22628656; DOI=10.1126/science.1218595; PMCID=PMC3526189;
RA   Jain, Mohit
RA   Nilsson, Roland
RA   Sharma, Sonia
RA   Madhusudhan, Nikhil
RA   Kitami, Toshimori
RA   Souza, Amanda L.
RA   Kafri, Ran
RA   Kirschner, Marc Wallace
RA   Clish, Clary B.
RA   Mootha, Vamsi Krishna
RT   "Metabolite profiling identifies a key role for glycine in rapid
RT   cancer cell proliferation.";
RL   Science 336:1040-1044(2012).
//
RX   PubMed=15299072; DOI=10.1158/1535-7163.895.3.8;
RA   Qin, Jian-Zhong
RA   Stennett, Lawrence
RA   Bacon, Patricia
RA   Bodner, Barbara
RA   Hendrix, Mary J.C.
RA   Seftor, Richard E.B.
RA   Seftor, Elisabeth A.
RA   Margaryan, Naira V.
RA   Pollock, Pamela M.
RA   Curtis, Amy
RA   Trent, Jeffrey M.
RA   Bennett, Frank
RA   Miele, Lucio
RA   Nickoloff, Brian J.
RT   "p53-independent NOXA induction overcomes apoptotic resistance of
RT   malignant melanomas.";
RL   Mol. Cancer Ther. 3:895-902(2004).
//
RX   PubMed=9598804; DOI=10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N;
RA   Walker, Graeme J.
RA   Flores, Jose F.
RA   Glendening, J. Michael
RA   Lin, Amy Hsiu-Ti
RA   Markl, Isabel D.C.
RA   Fountain, Jane W.
RT   "Virtually 100% of melanoma cell lines harbor alterations at the DNA
RT   level within CDKN2A, CDKN2B, or one of their downstream targets.";
RL   Genes Chromosomes Cancer 22:157-163(1998).
//
RX   PubMed=26405815; DOI=10.1371/journal.pone.0138210; PMCID=PMC4583389;
RA   Capaldo, Brian J.
RA   Roller, Devin Grimm
RA   Axelrod, Mark J.
RA   Koeppel, Alexander F.
RA   Petricoin, Emanuel F. 3rd
RA   Slingluff, Craig L. Jr.
RA   Weber, Michael J.
RA   Mackey, Aaron J.
RA   Gioeli, Daniel
RA   Bekiranov, Stefan
RT   "Systems analysis of adaptive responses to MAP kinase pathway blockade
RT   in BRAF mutant melanoma.";
RL   PLoS ONE 10:e0138210.1-e0138210.25(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu, Ma-Mie
RA   Selvaraj, Suresh K.
RA   Liang-Chu, May M.Y.
RA   Aghajani, Sahar
RA   Busse, Matthew
RA   Yuan, Jean
RA   Lee, Genee
RA   Peale, Franklin V.
RA   Klijn, Christiaan
RA   Bourgon, Richard
RA   Kaminker, Joshua S.
RA   Neve, Richard M.
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=18790768; DOI=10.1158/1535-7163.MCT-08-0431; PMCID=PMC2651569;
RA   Smalley, Keiran S.M.
RA   Lioni, Mercedes
RA   Dalla Palma, Maurizia
RA   Xiao, Min
RA   Desai, Brijal
RA   Egyhazi Brage, Suzanne
RA   Hansson, Johan
RA   Wu, Hong
RA   King, Alastair J.
RA   Van Belle, Patricia
RA   Elder, David E.
RA   Flaherty, Keith Thomas
RA   Herlyn, Meenhard
RA   Nathanson, Katherine L.
RT   "Increased cyclin D1 expression can mediate BRAF inhibitor resistance
RT   in BRAF V600E-mutated melanomas.";
RL   Mol. Cancer Ther. 7:2876-2883(2008).
//
RX   Patent=US4591572;
RA   Mattes, Michael Jules
RA   Thomson, Timothy M.
RA   Old, Lloyd John
RA   Lloyd, Kenneth Oliver
RT   "Pigmentation associated, differentiation antigen of human melanoma
RT   and autologous antibody.";
RL   Patent number US4591572, 27-May-1986.
//
RX   PubMed=22068913; DOI=10.1073/pnas.1111840108; PMCID=PMC3219108;
RA   Gillet, Jean-Pierre
RA   Calcagno, Anna Maria
RA   Varma, Sudhir
RA   Marino, Miguel
RA   Green, Lisa J.
RA   Vora, Meena I.
RA   Patel, Chirayu
RA   Orina, Josiah N.
RA   Eliseeva, Tatiana A.
RA   Singal, Vineet
RA   Padmanabhan, Raji
RA   Davidson, Ben
RA   Ganapathi, Ram
RA   Sood, Anil K.
RA   Rueda, Bo R.
RA   Ambudkar, Suresh V.
RA   Gottesman, Michael Marc
RT   "Redefining the relevance of established cancer cell lines to the
RT   study of mechanisms of clinical anti-cancer drug resistance.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:18708-18713(2011).
//
RX   PubMed=25950383; DOI=10.1111/pcmr.12380;
RA   Lazar, Ikrame
RA   Clement, Emily
RA   Ducoux-Petit, Manuelle
RA   Denat, Laurence
RA   Soldan, Vanessa
RA   Dauvillier, Stephanie
RA   Balor, Stephanie
RA   Burlet-Schiltz, Odile
RA   Larue, Lionel
RA   Muller, Catherine
RA   Nieto, Laurence
RT   "Proteome characterization of melanoma exosomes reveals a specific
RT   signature for metastatic cell lines.";
RL   Pigment Cell Melanoma Res. 28:464-475(2015).
//
RX   PubMed=11121133; DOI=10.1046/j.1523-1747.2000.00199.x;
RA   Lacal, Pedro Miguel
RA   Failla, Cristina M.
RA   Pagani, Elena
RA   Odorisio, Teresa
RA   Schietroma, Cataldo
RA   Falcinelli, Sabrina
RA   Zambruno, Giovanna
RA   D'Atri, Stefania
RT   "Human melanoma cells secrete and respond to placenta growth factor
RT   and vascular endothelial growth factor.";
RL   J. Invest. Dermatol. 115:1000-1007(2000).
//
RX   PubMed=6582512; DOI=10.1073/pnas.81.2.568; PMCID=PMC344720;
RA   Mattes, Michael Jules
RA   Cordon-Cardo, Carlos
RA   Lewis, John L. Jr.
RA   Old, Lloyd John
RA   Lloyd, Kenneth Oliver
RT   "Cell surface antigens of human ovarian and endometrial carcinoma
RT   defined by mouse monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984).
//
RX   PubMed=29492214; DOI=10.18632/oncotarget.23989; PMCID=PMC5823576;
RA   Sini, Maria Cristina
RA   Doneddu, Valentina
RA   Paliogiannis, Panagiotis
RA   Casula, Milena
RA   Colombino, Maria
RA   Manca, Antonella
RA   Botti, Gerardo
RA   Ascierto, Paolo Antonio
RA   Lissia, Amelia
RA   Cossu, Antonio
RA   Palmieri, Giuseppe
RT   "Genetic alterations in main candidate genes during melanoma
RT   progression.";
RL   Oncotarget 9:8531-8541(2018).
//